To determine whether USP1 can be used as an anti-HCC target, the anticancer effect of the USP1 inhibitor ML-323 was studied by treating various HCC cell lines with different ML-323 concentrations and evaluating cell viability. The gene discussed is USP1; the disease is hepatocellular carcinoma.